0001193125-24-280511.txt : 20241217 0001193125-24-280511.hdr.sgml : 20241217 20241217163436 ACCESSION NUMBER: 0001193125-24-280511 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 15 FILED AS OF DATE: 20241217 DATE AS OF CHANGE: 20241217 EFFECTIVENESS DATE: 20241217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] ORGANIZATION NAME: 02 Finance IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-283876 FILM NUMBER: 241556195 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 S-8 1 d905901ds8.htm S-8 S-8

As filed with the Securities and Exchange Commission on December 17, 2024

Registration No. 333-   

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

METLIFE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   13-4075851

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

200 Park Avenue

New York, New York 10166-0188

(Address of Principal Executive Offices) (Zip Code)

MetLife, Inc. 2025 Stock and Incentive Compensation Plan

(Full title of the plan)

Timothy J. Ring, Esq.

Senior Vice President & Secretary of MetLife, Inc.

MetLife, Inc.

200 Park Avenue

New York, New York 10166-0188

(212) 578-2211

(Name, address, including zip code, and telephone number,

including area code, of agent for service)

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 


REGISTRATION OF ADDITIONAL SECURITIES

EXPLANATORY NOTE

This Registration Statement on Form S-8 (this “Registration Statement”) is filed by MetLife, Inc. (the “Company”) to register 27,356,908 shares of the Company’s common stock, par value $0.01 per share (“Shares”), which may be offered or sold under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “2025 Plan”). The 2025 Plan covered by this Registration Statement was approved by the Company’s shareholders at its Annual Meeting of Shareholders held on June 18, 2024.

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

The document(s) containing the information specified in Part I of this Registration Statement will be sent or given to the participants under the 2025 Plan as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the “Securities Act”). Such documents are not being filed with the Securities and Exchange Commission (the “Commission”) either as part of this Registration Statement prepared in accordance with the requirements of Form S-8 under the Securities Act or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act. Such documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

Part II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents filed with the Commission by the Company are incorporated herein by reference and made a part hereof:

 

  (a)

The Company’s Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended December 31, 2023, filed on February 16, 2024, and the portions of the Company’s definitive proxy statement on Schedule 14A, filed on April 26, 2024, for its 2024 Annual Meeting of Shareholders incorporated by reference into the Form 10-K;

 

  (b)

The Company’s Quarterly Reports on Form 10-Q for the fiscal quarter ended March 31, 2024, filed on May  2, 2024, the fiscal quarter ended June 30, 2024, filed on August  1, 2024, and the fiscal quarter ended September 30, 2024, filed on November 1, 2024;

 

  (c)

The Company’s Current Reports on Form 8-K filed with the Commission on February 15, 2024, February  28, 2024, March 5, 2024, March  7, 2024, March 12, 2024, May  15, 2024, June 5, 2024, June  24, 2024, August 15, 2024, September 30, 2024, and November 15, 2024; and

 

  (d)

The description of the Company’s common stock contained in Exhibit 4.18 to the Form 10-K, including any subsequent amendment or any report subsequently filed for the purpose of updating such description.

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.

Item 4. Description of Securities.

Not Applicable.

Item 5. Interests of Named Experts and Counsel.

The validity of the issuance of the Shares which may be offered or sold under the 2025 Plan will be passed on for the Company by Timothy J. Ring, Senior Vice President & Secretary of the Company, who is eligible to receive awards under the 2025 Plan.

 

- 2 -


Item 6. Indemnification of Directors and Officers.

The Company’s Certificate of Incorporation contains a provision that is designed to limit the directors’ liability to the extent permitted by the Delaware General Corporation Law and any amendments to that law.

Specifically, directors will not be held liable to the Company or its stockholders for monetary damages for an act or omission in their capacity as a director, except for liability as a result of:

 

   

a breach of the duty of loyalty to the Company or its stockholders;

 

   

acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;

 

   

payment of an improper dividend or improper redemption or repurchase of the Company’s stock under Section 174 of the Delaware General Corporation Law; or

 

   

any transaction from which the director received an improper personal benefit.

The principal effect of the limitation on liability provision is that a stockholder is unable to prosecute an action for monetary damages against a director of the Company unless the stockholder can demonstrate one of the specified bases for liability. This provision, however, does not eliminate or limit director liability arising in connection with causes of action brought under the federal securities laws. The Company’s Certificate of Incorporation also does not eliminate the directors’ duty of care. The inclusion of the limitation on liability provision in the certificate may, however, discourage or deter stockholders or management from bringing a lawsuit against directors for a breach of their fiduciary duties, even though such an action, if successful, might otherwise have benefited the Company and its stockholders. This provision should not affect the availability of equitable remedies such as injunction or rescission based upon a director’s breach of the duty of care.

The Company’s By-Laws also provide that the Company will indemnify its directors and officers to the fullest extent permitted by Delaware law. The Company is required to indemnify its directors and officers for all judgments, fines, amounts paid in settlement, legal fees and other expenses reasonably incurred in connection with pending or threatened legal proceedings because of the director’s or officer’s position with the Company or its affiliates, that the director or officer serves at the Company’s request, subject to certain conditions, and to advance funds to the Company’s directors and officers to enable them to defend against such proceedings. To receive indemnification, the director or officer must succeed in the legal proceeding or act in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, in a manner he or she reasonably believed to be lawful.

The Company has in force and effect policies insuring its directors and officers against losses which they or any of them will become legally obligated to pay by reason of any actual or alleged error or misstatement or misleading statement or act or omission or neglect or breach of duty by the directors and officers in the discharge of their duties, individually or collectively, or any matter claimed against them by reason of their being “or in the capacity as” directors or officers. Such coverage is limited by the specific terms and provisions of the insurance policies.

Item 7. Exemption From Registration Claimed.

Not applicable.

Item 8. Exhibits.

 

Exhibit

Number

  

Description

4.1    Amended and Restated Certificate of Incorporation of MetLife, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K filed on March 1, 2017).
4.2    Certificate of Amendment of Amended and Restated Certificate of Incorporation of MetLife, Inc., dated October 23, 2017 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with on October 24, 2017).
4.3    Amended and Restated By-Laws of MetLife, Inc., effective October 3, 2023 (incorporated by reference to Exhibit 3.2 on the Company’s Current Report on Form 8-K filed on October 5, 2023).
5.1*    Opinion of Timothy J. Ring, Esq., Senior Vice President and Secretary of MetLife, Inc., who has acted as counsel for the Company, regarding the validity of the securities registered hereunder.
23.1*    Consent of Deloitte & Touche LLP. Independent Registered Public Accounting Firm
23.2*    Consent of Timothy J. Ring, Esq., Senior Vice President and Secretary of the Company (included in Exhibit 5.1).
24.1*    Powers of Attorney (included on the signature page to this Registration Statement).
99.1    MetLife, Inc. 2025 Stock and Incentive Compensation Plan (incorporated by reference to Appendix C to the Company’s definitive proxy statement on Form 14A for the 2024 Annual Meeting of Shareholders filed on April 26, 2024).
107*    Filing Fee Table.

 

*

Filed Herewith

 

- 3 -


Item 9. Undertakings.

(a) The Company hereby undertakes:

 

  (1)

To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) to reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) of the Securities Act if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in this effective Registration Statement; and

(iii) to include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

 

  (2)

That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (3)

To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

- 4 -


SIGNATURES

The Registrant. Pursuant to the requirements of the Securities Act, the Company as registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on this 17th day of December, 2024.

 

METLIFE, INC.
By:  

/s/ Timothy J. Ring

  Name:   Timothy J. Ring
  Title:  

Senior Vice President and Secretary

MetLife, Inc.

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned hereby constitutes and appoints Michel A. Khalaf, President and Chief Executive Officer, John D. McCallion, Executive Vice President and Chief Financial Officer, Tamara L. Schock, Executive Vice President and Chief Accounting Officer and Monica Curtis, Executive Vice President and Chief Legal Officer, or any of them and their respective successors from time to time in the offices of President and Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and Chief Legal Officer, as the case may be, as true and lawful attorneys-in-fact and agents, each acting alone, with full powers of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign individually and not collectively, (i) this Registration Statement and any and all amendments and supplements to this Registration Statement on Form S-8, including, without limitation, post-effective amendments, and other instruments appropriate or necessary in connection therewith, to attest the seal of the Company thereon, and to file the same with the Commission, granting to said attorneys-in-fact and agents, or their substitutes, and each of them, the full power and authority to do and perform in the name and on behalf of each of said officers and directors, or both, as the case may be, every act whatsoever which may be appropriate or necessary as set forth in this Registration Statement, including any amendments or supplements thereto, including, without limitation, post-effective amendments to this Registration Statement, and to take or cause to be taken any and all such actions in connection therewith in the name and on behalf of the Company as they, in their sole discretion, deem appropriate or necessary and (ii) any and all other instruments which any of such attorneys-in-fact and agents deems necessary or advisable to comply with the Securities Act and the rules, regulations, and requirements of the Commission and Blue Sky or other state securities laws and regulations, and does hereby grant unto each such attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that each said attorney-in-fact and agent, or any substitute therefor, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

NAME    TITLE    DATE

/s/ Michel A. Khalaf

Michel A. Khalaf

   President, Chief Executive Officer and Director (Principal Executive Officer)    December 17, 2024

/s/ John D. McCallion

John D. McCallion

   Executive Vice President and Chief Financial Officer (Principal Financial Officer)    December 17, 2024

/s/ Tamara L. Schock

Tamara L. Schock

   Executive Vice President and Chief Accounting Officer (Principal Accounting Officer)    December 17, 2024

/s/ Cheryl W. Grisé

Cheryl W. Grisé

   Director    December 17, 2024

 

- 5 -


/s/ Carlos M. Gutierrez

Carlos M. Gutierrez

   Director    December 17, 2024

/s/ Carla A. Harris

Carla A. Harris

   Director    December 17, 2024

/s/ Laura J. Hay

Laura J. Hay

   Director    December 17, 2024

/s/ David L. Herzog

David L. Herzog

   Director    December 17, 2024

/s/ R. Glenn Hubbard

R. Glenn Hubbard

   Chairman of the Board    December 17, 2024

/s/ Jeh C. Johnson

Jeh C. Johnson

   Director    December 17, 2024

/s/ Edward J. Kelly, III

Edward J. Kelly, III

   Director    December 17, 2024

/s/ William E. Kennard

William E. Kennard

   Director    December 17, 2024

/s/ Diana L. McKenzie

Diana L. McKenzie

   Director    December 17, 2024

/s/ Denise M. Morrison

Denise M. Morrison

   Director    December 17, 2024

/s/ Mark A. Weinberger

Mark A. Weinberger

   Director    December 17, 2024

 

 

- 6 -

EX-5.1 2 d905901dex51.htm EX-5.1 EX-5.1

Exhibit 5.1

OPINION OF TIMOTHY J. RING, ESQ.

December 17, 2024

MetLife, Inc.

200 Park Avenue

New York, New York 10166-0188

Ladies and Gentlemen:

I am Senior Vice President & Secretary of MetLife, Inc., a Delaware corporation (the “Company”). I am familiar with the Registration Statement on Form S-8 (the “Registration Statement”) to be filed under the Securities Act of 1933, as amended (the “Act”), relating to the 27,356,908 shares of the Company’s common stock, par value $0.01 per share (the “Shares”) to be issued pursuant to the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “2025 Plan”).

I or other in-house attorneys for the Company over whom I exercise general supervisory authority have reviewed such documents and records as we have deemed necessary or appropriate as a basis for the opinion set forth herein. In making such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies and the authenticity of the originals of such copies.

Based upon and subject to the limitations, assumptions, qualifications and exceptions set forth herein, I am of the opinion that, when issued in accordance with the terms of the 2025 Plan, the 27,356,908 Shares will be validly issued, fully paid and non-assessable.

I am a member of the bar of the State of New York and I do not express an opinion herein concerning any laws other than the laws of the United States of America and the General Corporation Law of the State of Delaware.

I hereby consent to the use of this opinion as an exhibit to the Registration Statement and to the use of my name under the heading “Interests of Named Experts and Counsel” therein.

 

Very truly yours,
 

/s/ Timothy J. Ring

Name:   Timothy J. Ring
Title:  

Senior Vice President and Secretary

MetLife, Inc.

 

- 7 -

EX-23.1 3 d905901dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 15, 2024, relating to the consolidated financial statements of MetLife, Inc. and subsidiaries (“MetLife”), and the effectiveness of MetLife’s internal control over financial reporting, appearing in the Annual Report on Form 10-K of MetLife for the fiscal year ended December 31, 2023.

/s/ DELOITTE & TOUCHE LLP

December 17, 2024

 

- 8 -

EX-FILING FEES 4 d905901dexfilingfees.htm EX-FILING FEES EX-FILING FEES
0001099219METLIFE INCEX-FILING FEESfalse 0001099219 2024-12-17 2024-12-17 0001099219 1 2024-12-17 2024-12-17 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
CALCULATION OF FILING FEE TABLE
Form
S-8
(Form Type)
MetLife, Inc.
(Exact name of registrant as specified in its charter)
Table 1: Newly Registered Securities
 
               
Security Type  
Security
Class
Title
  Fee Calculation
Rule
  Amount
Registered
(1)
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum Aggregate
Offering Price
 
Fee
Rate
  Amount of
Registration
Fee
               
Equity   Common Stock, par value $0.01 per share   Rule 457(c) and 457(h)   27,356,908
 (2)
  $81.01  
$2,216,183,117
  0.00015310  
$339,298
         
Total Offering Amounts:    
$2,216,183,117
   
$339,298
         
Total Fee Offsets:        
         
Net Fee Due:              
$339,298
 
  (1)
Pursuant to Rule 416(a) under the
Sec
urities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form
S-8
(the “Registration Statement”) shall also cover any additional shares of common stock, $0.01 par value per share (the “Shares”), of MetLife, Inc. (the “Company”) that become issuable under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “2025 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Company’s outstanding Shares.
 
  (2)
The 27,356,908 Shares issuable pursuant to the 2025 Plan consist of:
  a.
22,500,000 Shares,
reduced by
108,797 Shares subject to awards granted on or after March 28, 2024 and through December 31, 2024 under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife, Inc. 2015
Non-Management
Director Stock Compensation Plan (collectively, the “Prior Plans”); and
  b.
4,965,705 Shares, which represents the aggregate maximum number of Shares subject to outstanding awards under the Prior Plans as of November 15, 2024, that could by their terms be forfeited (or otherwise lapse, expire, terminate or be cancelled) on or after January 1, 2025 (the effective date of the 2025 Plan) and become available for grant under the 2025 Plan.
The registration statements on Form
S-8
applicable to the Prior Plans will remain in place. The Company intends to file a post-effective amendment to deregister from such registration statements those Shares which remain unissued and uncovered by awards under the Prior Plans after there are no longer any such awards out
stan
d
in
g
un
der the Prior Plans.
 
  (3)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these Shares are calculated based on $81.01 per share, the average of the high and low prices of the Shares as reported on the New York Stock Exchange on December 11, 2024, a date within five business days prior to the filing of this Registration Statement.
Table 2: Fee Offset Claims and Sources
Not Applicable
 
- 9 -
XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.4
Submission
Dec. 17, 2024
Submission [Line Items]  
Central Index Key 0001099219
Registrant Name METLIFE INC
Form Type S-8
Submission Type S-8
Fee Exhibit Type EX-FILING FEES
XML 7 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Offerings - Offering: 1
Dec. 17, 2024
USD ($)
shares
Offering:  
Fee Previously Paid false
Other Rule true
Security Type Equity
Security Class Title Common Stock, par value $0.01 per share
Amount Registered | shares 27,356,908
Proposed Maximum Offering Price per Unit 81.01
Maximum Aggregate Offering Price $ 2,216,183,117
Fee Rate 0.01531%
Amount of Registration Fee $ 339,298
Offering Note
  (1)
Pursuant to Rule 416(a) under the
Sec
urities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form
S-8
(the “Registration Statement”) shall also cover any additional shares of common stock, $0.01 par value per share (the “Shares”), of MetLife, Inc. (the “Company”) that become issuable under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “2025 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Company’s outstanding Shares.
 
  (2)
The 27,356,908 Shares issuable pursuant to the 2025 Plan consist of:
  a.
22,500,000 Shares,
reduced by
108,797 Shares subject to awards granted on or after March 28, 2024 and through December 31, 2024 under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife, Inc. 2015
Non-Management
Director Stock Compensation Plan (collectively, the “Prior Plans”); and
  b.
4,965,705 Shares, which represents the aggregate maximum number of Shares subject to outstanding awards under the Prior Plans as of November 15, 2024, that could by their terms be forfeited (or otherwise lapse, expire, terminate or be cancelled) on or after January 1, 2025 (the effective date of the 2025 Plan) and become available for grant under the 2025 Plan.
The registration statements on Form
S-8
applicable to the Prior Plans will remain in place. The Company intends to file a post-effective amendment to deregister from such registration statements those Shares which remain unissued and uncovered by awards under the Prior Plans after there are no longer any such awards out
stan
d
in
g
un
der the Prior Plans.
XML 8 R3.htm IDEA: XBRL DOCUMENT v3.24.4
Fees Summary
Dec. 17, 2024
USD ($)
Fees Summary [Line Items]  
Total Offering $ 2,216,183,117
Total Fee Amount 339,298
Total Offset Amount 0
Net Fee $ 339,298
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.4 html 2 19 1 false 1 0 false 3 false false R1.htm 995210 - Document - Submission Sheet http://xbrl.sec.gov/ffd/role/document/submissionTable Submission Cover 1 false false R2.htm 995211 - Document - Offerings Sheet http://xbrl.sec.gov/ffd/role/document/feesOfferingTable Offerings Cover 2 false false R3.htm 995215 - Document - Fees Summary Sheet http://xbrl.sec.gov/ffd/role/document/feesSummaryTable Fees Summary Cover 3 false false All Reports Book All Reports d905901dexfilingfees.htm http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ffd/2024q2 false false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d905901dexfilingfees.htm": { "dts": { "inline": { "local": [ "d905901dexfilingfees.htm" ] }, "schema": { "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" ] } }, "keyStandard": 19, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2024": 2, "http://xbrl.sec.gov/ffd/2024q2": 2 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 107, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/ffd/2024q2": 17, "http://xbrl.sec.gov/dei/2024": 2 }, "report": { "R1": { "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable", "longName": "995210 - Document - Submission", "shortName": "Submission", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P12_17_2024To12_17_2024", "name": "ffd:FormTp", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P12_17_2024To12_17_2024", "name": "ffd:FormTp", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "longName": "995211 - Document - Offerings", "shortName": "Offerings", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "P12_17_2024To12_17_2024_1TypedMemberffdOfferingAxis", "name": "ffd:FeesOthrRuleFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P12_17_2024To12_17_2024_1TypedMemberffdOfferingAxis", "name": "ffd:FeesOthrRuleFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true } }, "R3": { "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable", "longName": "995215 - Document - Fees Summary", "shortName": "Fees Summary", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "3", "firstAnchor": { "contextRef": "P12_17_2024To12_17_2024", "name": "ffd:TtlOfferingAmt", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P12_17_2024To12_17_2024", "name": "ffd:TtlOfferingAmt", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d905901dexfilingfees.htm", "first": true, "unique": true } } }, "tag": { "ffd_AggtRedRpPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtRedRpPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, FY" } } }, "auth_ref": [ "r1" ] }, "ffd_AggtRedRpPricPrrFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtRedRpPricPrrFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY" } } }, "auth_ref": [ "r1" ] }, "ffd_AggtSalesPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtSalesPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Sales Price, Fiscal Year", "terseLabel": "Aggregate Sales Price" } } }, "auth_ref": [ "r1" ] }, "ffd_AmtRedCdts": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtRedCdts", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Amount of Redemption Credits", "terseLabel": "Redemption Credits" } } }, "auth_ref": [ "r1" ] }, "ffd_AmtSctiesRcvd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Received", "terseLabel": "Amount of Securities Received", "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r6" ] }, "ffd_AmtSctiesRegd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtSctiesRegd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Registered", "terseLabel": "Amount Registered", "documentation": "The amount of securities being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_CeasedOprsDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CeasedOprsDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Ceased Operations Date", "terseLabel": "Ceased Operations Date" } } }, "auth_ref": [] }, "ffd_CfwdFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Form Type", "terseLabel": "Carry Forward Form Type", "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrevslyPdFee": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrevslyPdFee", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Previously Paid Fee", "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward", "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrrFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrrFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Prior Effective Date", "terseLabel": "Carry Forward Initial Effective Date", "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward File Number", "terseLabel": "Carry Forward File Number", "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r2" ] }, "ffd_CmbndPrspctsItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsItemAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Item [Axis]", "terseLabel": "Combined Prospectus", "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission." } } }, "auth_ref": [ "r1" ] }, "ffd_CmbndPrspctsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsLineItems", "lang": { "en-us": { "role": { "label": "Combined Prospectus [Line Items]", "terseLabel": "Combined Prospectus:" } } }, "auth_ref": [ "r1" ] }, "ffd_CmbndPrspctsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus [Table]", "terseLabel": "Combined Prospectus Table" } } }, "auth_ref": [ "r1" ] }, "ffd_CombinedProspectusTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CombinedProspectusTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Table [N/A]", "terseLabel": "Combined Prospectus Table N/A" } } }, "auth_ref": [] }, "ffd_CshPdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CshPdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Paid by Registrant in Transaction", "terseLabel": "Cash Consideration Paid", "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r12" ] }, "ffd_CshRcvdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CshRcvdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Received by Registrant in Transaction", "terseLabel": "Cash Consideration Received", "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r12" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "ffd_FeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Amount", "terseLabel": "Amount of Registration Fee", "documentation": "Total amount of registration fee (amount due after offsets)." } } }, "auth_ref": [ "r1" ] }, "ffd_FeeExhibitTp": { "xbrltype": "feeExhibitTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeExhibitTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Fee Exhibit Type", "terseLabel": "Fee Exhibit Type" } } }, "auth_ref": [] }, "ffd_FeeIntrstAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Fee Interest Amount", "terseLabel": "Interest Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Note", "terseLabel": "Fee Note" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeNoteMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeNoteMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fee Note Maximum Aggregate Offering Price", "terseLabel": "Fee Note MAOP" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeRate": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeRate", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Rate", "terseLabel": "Fee Rate", "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission." } } }, "auth_ref": [ "r1" ] }, "ffd_FeesOthrRuleFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeesOthrRuleFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fees, Other Rule [Flag]", "terseLabel": "Other Rule", "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r1" ] }, "ffd_FeesSummaryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeesSummaryLineItems", "lang": { "en-us": { "role": { "label": "Fees Summary [Line Items]", "terseLabel": "Fees Summary:" } } }, "auth_ref": [ "r1" ] }, "ffd_FnlPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FnlPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Final Prospectus [Flag]", "terseLabel": "Final Prospectus" } } }, "auth_ref": [ "r1" ] }, "ffd_FormTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Form Type", "terseLabel": "Form Type" } } }, "auth_ref": [] }, "ffd_GnlInstrIIhiFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "GnlInstrIIhiFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "General Instruction II.H,I [Flag]", "terseLabel": "General Instruction II.H,I" } } }, "auth_ref": [] }, "ffd_IssrBizAdrCity": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrCity", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, City", "terseLabel": "City" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStatOrCtryCd": { "xbrltype": "stateOrCountryCodeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStatOrCtryCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, State or Country Code", "terseLabel": "State or Country Code" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt1": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStrt1", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 1", "terseLabel": "Street 1" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt2": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStrt2", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 2", "terseLabel": "Street 2" } } }, "auth_ref": [] }, "ffd_IssrBizAdrZipCd": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrZipCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Zip Code", "terseLabel": "Zip Code" } } }, "auth_ref": [] }, "ffd_IssrNm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Name", "terseLabel": "Issuer Name" } } }, "auth_ref": [] }, "ffd_MaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "MaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Aggregate Offering Price", "terseLabel": "Maximum Aggregate Offering Price", "documentation": "The maximum aggregate offering price for the offering that is being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_MaxOfferingPricPerScty": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "MaxOfferingPricPerScty", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Offering Price per Security", "terseLabel": "Proposed Maximum Offering Price per Unit", "documentation": "The maximum offering price per share/unit being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_NetFeeAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NetFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Net Fee Amount", "terseLabel": "Net Fee" } } }, "auth_ref": [ "r1" ] }, "ffd_NetSalesAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NetSalesAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Net Sales Amount", "terseLabel": "Net Sales" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvDsclsr": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvDsclsr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure", "terseLabel": "Narrative Disclosure" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvMaxAggtAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvMaxAggtAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Amount", "terseLabel": "Narrative - Max Aggregate Offering Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Price", "terseLabel": "Narrative - Max Aggregate Offering Price" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Axis]", "terseLabel": "Offering", "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission." } } }, "auth_ref": [] }, "ffd_OfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingLineItems", "lang": { "en-us": { "role": { "label": "Offering [Line Items]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Note", "terseLabel": "Offering Note" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Title", "terseLabel": "Security Class Title", "documentation": "The title of the class of securities being registered (for each class being registered)." } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Type", "terseLabel": "Security Type", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Table]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offering Table [N/A]", "terseLabel": "Offering Table N/A" } } }, "auth_ref": [] }, "ffd_OffsetAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset [Axis]", "terseLabel": "Offset", "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission." } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetClmInitlFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmInitlFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claim Initial Filing Date", "terseLabel": "Initial Filing Date", "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetClmdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Amount", "terseLabel": "Fee Offset Claimed", "documentation": "The amount of offsetting fees being claimed." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetClmdInd": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmdInd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Indicator", "terseLabel": "Offset Claimed" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetExpltnForClmdAmt": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetExpltnForClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Explanation for Claimed Amount", "terseLabel": "Explanation for Claimed Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetLineItems", "lang": { "en-us": { "role": { "terseLabel": "Offset:", "label": "Offset [Line Items]" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Note", "terseLabel": "Offset Note" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetPrrFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Fee Amount", "terseLabel": "Fee Paid with Fee Offset Source", "documentation": "The fee prevoiusly paid from which an offset is being derived." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior File Number", "terseLabel": "File Number", "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFilerNm": { "xbrltype": "filerNameItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFilerNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Filer Name", "terseLabel": "Registrant or Filer Name", "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Form Type", "terseLabel": "Form or Filing Type", "documentation": "The Form Type of the offset filing." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrNbOfUnsoldScties": { "xbrltype": "nonNegativeIntegerItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrNbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Number of Securities", "terseLabel": "Unsold Securities Associated with Fee Offset Claimed", "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Title", "terseLabel": "Security Title Associated with Fee Offset Claimed", "documentation": "The title of the class of securities from which offset fees were derived." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Type", "terseLabel": "Security Type Associated with Fee Offset Claimed", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrUnsoldOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrUnsoldOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Offering Amount", "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed", "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetSrcFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetSrcFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Source Filing Date", "terseLabel": "Filing Date", "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Offset Payment:", "label": "Offset [Table]" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offset Table [N/A]", "terseLabel": "Offset Table N/A" } } }, "auth_ref": [] }, "ffd_PrevslyPdFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "PrevslyPdFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Previously Paid [Flag]", "terseLabel": "Fee Previously Paid" } } }, "auth_ref": [] }, "ffd_RegnFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "RegnFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Registration File Number", "terseLabel": "Registration File Number" } } }, "auth_ref": [] }, "ffd_RptgFsclYrEndDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "RptgFsclYrEndDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Reporting Fiscal Year End Date", "terseLabel": "Reporting FY End Date" } } }, "auth_ref": [] }, "ffd_Rule011Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule011Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 0-11 [Flag]", "terseLabel": "Rule 0-11" } } }, "auth_ref": [] }, "ffd_Rule011a2OffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule011a2OffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 0-11(a)(2) Offset", "label": "Rule 0-11(a)(2) Offset [Flag]" } } }, "auth_ref": [] }, "ffd_Rule415a6Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule415a6Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 415(a)(6) [Flag]", "terseLabel": "Rule 415(a)(6)", "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward." } } }, "auth_ref": [ "r2" ] }, "ffd_Rule429AggtOfferingAmt": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429AggtOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Aggregate Offering Amount", "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered", "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429CmbndPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429CmbndPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Combined Prospectus [Flag]", "terseLabel": "Rule 429", "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429EarlierFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429EarlierFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier File Number", "terseLabel": "File Number", "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429EarlierFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429EarlierFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier Form Type", "terseLabel": "Form Type", "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429InitlFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429InitlFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Initial Effective Date", "terseLabel": "Initial Effective Date", "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429NbOfUnsoldScties": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429NbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Number Of Unsold Securities", "terseLabel": "Amount of Securities Previously Registered", "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429PrspctsNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429PrspctsNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Prospectus Note", "terseLabel": "Combined Prospectus Note" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule429SctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429SctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Title", "terseLabel": "Security Class Title" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule429SctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429SctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Type", "terseLabel": "Security Type" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule457aFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457aFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(a) [Flag]", "terseLabel": "Rule 457(a)", "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due." } } }, "auth_ref": [ "r4" ] }, "ffd_Rule457bOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457bOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(b) Offset [Flag]", "terseLabel": "Rule 457(b) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)." } } }, "auth_ref": [ "r5" ] }, "ffd_Rule457fFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457fFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(f) [Flag]", "terseLabel": "Rule 457(f)", "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r6" ] }, "ffd_Rule457oFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457oFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(o) [Flag]", "terseLabel": "Rule 457(o)", "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due." } } }, "auth_ref": [ "r7" ] }, "ffd_Rule457pOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457pOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(p) Offset [Flag]", "terseLabel": "Rule 457(p) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)." } } }, "auth_ref": [ "r8" ] }, "ffd_Rule457rFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457rFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(r) [Flag]", "terseLabel": "Rule 457(r)" } } }, "auth_ref": [ "r9" ] }, "ffd_Rule457sFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457sFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(s) Flag", "terseLabel": "Rule 457(s)" } } }, "auth_ref": [ "r10" ] }, "ffd_Rule457uFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457uFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(u) [Flag]", "terseLabel": "Rule 457(u)", "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due." } } }, "auth_ref": [ "r11" ] }, "ffd_Scties424iAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Axis]", "terseLabel": "Securities, 424I" } } }, "auth_ref": [ "r1" ] }, "ffd_Scties424iLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iLineItems", "lang": { "en-us": { "role": { "label": "Securities, 424I [Line Items]", "terseLabel": "Securities, 424I:" } } }, "auth_ref": [ "r1" ] }, "ffd_Scties424iTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Table]", "terseLabel": "Securities, 424I Table" } } }, "auth_ref": [ "r1" ] }, "ffd_Securities424iTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Securities424iNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Securities 424I [N/A]", "terseLabel": "Securities 424I N/A" } } }, "auth_ref": [] }, "ffd_SubmissionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "SubmissionLineItems", "lang": { "en-us": { "role": { "label": "Submission [Line Items]", "terseLabel": "Items" } } }, "auth_ref": [] }, "ffd_SubmissnTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "SubmissnTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Submission Type", "terseLabel": "Submission Type" } } }, "auth_ref": [] }, "ffd_TermntnCmpltnWdrwl": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TermntnCmpltnWdrwl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Termination / Completion / Withdrawal Statement", "terseLabel": "Termination / Withdrawal Statement" } } }, "auth_ref": [] }, "ffd_TtlFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee Amount", "terseLabel": "Total Fee Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlFeeAndIntrstAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlFeeAndIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee and Interest Amount", "terseLabel": "Total Fee and Interest Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offering Amount", "terseLabel": "Total Offering" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlOffsetAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlOffsetAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offset Amount", "terseLabel": "Total Offset Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlPrevslyPdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlPrevslyPdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Previously Paid Amount", "terseLabel": "Previously Paid Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlTxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlTxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Transaction Valuation", "terseLabel": "Total Transaction Valuation" } } }, "auth_ref": [ "r1" ] }, "ffd_TxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Transaction Valuation", "terseLabel": "Transaction Valuation" } } }, "auth_ref": [] }, "ffd_ValSctiesRcvd": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "ValSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received", "terseLabel": "Value of Securities Received", "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r6" ] }, "ffd_ValSctiesRcvdPerShr": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "ValSctiesRcvdPerShr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received, Per Share", "terseLabel": "Value of Securities Received, Per Share", "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "415", "Subsection": "a" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "429" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "f" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "o" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "p" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "r" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "s" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "u" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Subsection": "f", "Section": "457" } } } ZIP 16 0001193125-24-280511-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-280511-xbrl.zip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end XML 17 d905901dexfilingfees_htm.xml IDEA: XBRL DOCUMENT 0001099219 2024-12-17 2024-12-17 0001099219 1 2024-12-17 2024-12-17 iso4217:USD pure shares 0001099219 METLIFE INC EX-FILING FEES false S-8 S-8 Equity Common Stock, par value $0.01 per share true 27356908 81.01 2216183117 0.0001531 339298 2216183117 339298 0 339298 <table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pursuant to Rule 416(a) under the <div style="display:inline;">Sec</div>urities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-8</div> (the “Registration Statement”) shall also cover any additional shares of common stock, $0.01 par value per share (the “Shares”), of MetLife, Inc. (the “Company”) that become issuable under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “2025 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Company’s outstanding Shares. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The 27,356,908 Shares issuable pursuant to the 2025 Plan consist of: </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:12%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">22,500,000 Shares, <div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">reduced by</div></div> 108,797 Shares subject to awards granted on or after March 28, 2024 and through December 31, 2024 under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife, Inc. 2015 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-Management</div> Director Stock Compensation Plan (collectively, the “Prior Plans”); and </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:12%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">4,965,705 Shares, which represents the aggregate maximum number of Shares subject to outstanding awards under the Prior Plans as of November 15, 2024, that could by their terms be forfeited (or otherwise lapse, expire, terminate or be cancelled) on or after January 1, 2025 (the effective date of the 2025 Plan) and become available for grant under the 2025 Plan. </div></td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">The registration statements on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-8</div> applicable to the Prior Plans will remain in place. The Company intends to file a post-effective amendment to deregister from such registration statements those Shares which remain unissued and uncovered by awards under the Prior Plans after there are no longer any such awards out<div style="display:inline;">stan</div>d<div style="display:inline;">in</div>g <div style="display:inline;">un</div>der the Prior Plans. </div>